Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
WW International, Inc. (WW)
NASDAQ:WW
Holding WW?
Track your performance easily
Earnings Data
Report Date
Mar 04, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.01Last Year’s EPS
-0.06Same Quarter Last Year
Moderate Sell
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 01, 2018
|% Change Since: 3.45%
|Next Earnings Date:Aug 06, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there are notable achievements such as improved gross margin, successful product launches, and growth in clinical subscribers, there are significant challenges including subscriber and revenue declines, increased customer acquisition costs, and noncash impairment charges.Company Guidance
During the WW International Q3 2024 earnings call, several key metrics and strategic initiatives were discussed. The company reported a 9% year-over-year decline in subscribers, ending the quarter with 3.7 million subscribers, and total revenue of $193 million, down 6% from the previous year. Despite challenges, such as increased customer acquisition costs and competition, the company remains confident in its unique market position and is on track to achieve its full-year guidance. Notably, the clinical subscriber base grew by 71% year-over-year, contributing $19.1 million in revenue. The company also announced it is on track for a $100 million cost reduction by the end of 2025, with $20 million expected in 2024. Marketing expenses were reduced by 8% year-over-year, and adjusted operating income was reported at $36 million, reflecting an 18.5% operating margin. The company is focusing on initiatives such as brand revitalization, digital experience integration, and expanding access to weight loss medications to drive future growth.Improved Gross Margin
Adjusted gross margin reached a record high of 69.1% in Q3 2024, up from 66.2% in the prior year and 67.9% last quarter.
Successful Launch of Compounded Semaglutide
The launch led to positive impacts on sign-ups with the single highest day for clinic sign-ups in 2024, improving clinic member retention from 6.5 months to 7.5 months in Q3.
Clinical Subscribers Growth
Clinical subscribers grew by 71% compared to the prior year, contributing $19.1 million in clinical subscription revenues.
On Track with Cost Savings Initiatives
The company remains on track for the $100 million cost action, with significant savings expected in Q4 and beyond.
---
WW Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
WW Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $1.16 | $1.04 | -10.34% |
| Aug 01, 2024 | $1.07 | $0.88 | -17.76% |
| May 02, 2024 | $1.89 | $2.09 | +10.58% |
| Feb 28, 2024 | $3.82 | $3.12 | -18.32% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does WW International, Inc. (WW) report earnings?
WW International, Inc. (WW) is schdueled to report earning on Mar 04, 2025, TBA Not Confirmed.
What is WW International, Inc. (WW) earnings time?
WW International, Inc. (WW) earnings time is at Mar 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is WW EPS forecast?
WW EPS forecast for the fiscal quarter 2024 (Q4) is 0.01.
---
